Lynn F. Butterly

TL;DR: Progress against CRC can be accelerated by increasing access to guideline‐recommended screening and high‐quality treatment, particularly among Alaska Natives, and elucidating causes for rising incidence in young and middle‐aged adults.

TL;DR: Adenomas 5-10 mm in size harbor pathologically significant histology, and the need for removal of these lesions must be addressed to optimize colorectal cancer prevention.

TL;DR: Polyp and adenoma detection rates were highest among endoscopists with 9’min median normal withdrawal time, and detection of CSSPs reached its highest levels at 8–9 min.

TL;DR: Four strategies for reducing CRC in persons with familial risk are suggested: improving the collection and utilization of the FH of cancer, establishing a consensus for screening guidelines by FH, enhancing provider‐patient knowledge of guidelines and communication about CRC risk, and encouraging survivors to promote screening within their families and partnering with existing screening programs to expand their reach to high‐risk groups.

TL;DR: Derived from ADR, the primary colonoscopy quality indicator, the results suggest potential SDR benchmarks that may guide adequate serrated polyp detection that may be essential to the prevention of CRC associated with the serrated pathway.